Found: 15
Select item for more details and to access through your institution.
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next‐generation sequencing in multiple myeloma treated with quadruplet therapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1170, doi. 10.1002/ajh.26640
- By:
- Publication type:
- Article
Management of relapsed and refractory multiple myeloma in modern times: Incorporating new agents into decision-making.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. 1044, doi. 10.1002/ajh.24478
- By:
- Publication type:
- Article
Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00815
- By:
- Publication type:
- Article
KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 8, p. 526, doi. 10.1016/j.clml.2021.03.013
- By:
- Publication type:
- Article
Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 14, p. 7795, doi. 10.3390/ijms25147795
- By:
- Publication type:
- Article
Cardiovascular Complications Associated with Multiple Myeloma Therapies: Incidence, Pathophysiology, and Management.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 4, p. N.PAG, doi. 10.1007/s11912-019-0784-4
- By:
- Publication type:
- Article
Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara‐KRd), autologous hematopoietic cell transplantation, and measurable residual disease‐response‐adapted treatment cessation
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 775, doi. 10.1002/jha2.736
- By:
- Publication type:
- Article
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 4, p. 555, doi. 10.1111/bjh.16653
- By:
- Publication type:
- Article
Challenges and opportunities in the assessment of measurable residual disease in multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. 807, doi. 10.1111/bjh.16130
- By:
- Publication type:
- Article
Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 2, p. 271, doi. 10.1111/bjh.14970
- By:
- Publication type:
- Article
The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 481, doi. 10.1111/bjh.14585
- By:
- Publication type:
- Article
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 358, doi. 10.1002/cam4.4451
- By:
- Publication type:
- Article
Metabolomic signatures of carfilzomib‐related cardiotoxicity in patients with multiple myeloma.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 5, p. 1, doi. 10.1111/cts.13828
- By:
- Publication type:
- Article
Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article